InTest Resultados de beneficios anteriores
Pasado controles de criterios 1/6
Los beneficios de InTest han disminuido a una tasa media anual de -28.2%, mientras que en la industria Semiconductor los beneficios crecieron en un 1.8% anualmente. Los ingresos han ido creciendo a una tasa media de 9.5% al año. La rentabilidad financiera de InTest es de 0.6%, y sus márgenes netos son de 0.5%.
Información clave
-28.18%
Tasa de crecimiento de los beneficios
-29.73%
Tasa de crecimiento del BPA
| Crecimiento de la industria Semiconductor | 27.66% |
| Tasa de crecimiento de los ingresos | 9.55% |
| Rentabilidad financiera | 0.57% |
| Margen neto | 0.49% |
| Última actualización de beneficios | 31 Mar 2026 |
Actualizaciones de resultados anteriores recientes
Recent updates
INTT: 2026 Guidance And New Leadership Will Support Higher Repricing
Analysts have raised their price target on inTEST to $19.33 from $17.67, citing updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E following recent research. What's in the News inTEST raised its full-year 2026 revenue guidance to a range of $130 million to $135 million, citing first-quarter outperformance and improving market conditions.
INTT: Solid 2026 Outlook And Q4 Execution Will Support Measured Upside Potential
Analysts have raised their price expectations for inTEST to a range of about $14 to $19. They cited better-than-expected Q4 results and "solid" guidance through 2026 as the basis for the higher targets.
INTT: Multiyear Guidance Will Test Rich Rogoff’s Execution Against High Expectations
Analysts have lifted their price target on inTEST to $14 from $10, citing better-than-expected Q4 results, solid 2026 guidance, and updated assumptions for higher revenue growth and profit margins within a similar forward P/E framework. Analyst Commentary Recent research updates point to a mixed read for inTEST, with higher price targets anchored to Q4 outperformance and 2026 guidance, but also a clear sense that valuation, execution, and growth risk still matter for investors.INTT: Q4 Beat And 2026 Outlook Will Support Higher Market Repricing
Analyst price targets on inTEST have shifted from a prior fair value estimate of about $10 to roughly $17.67, with the move supported by recent Q4 outperformance and "solid" 2026 guidance that prompted Street targets in the $14 to $19 range. Analyst Commentary Bullish Takeaways Bullish analysts point to the better than expected Q4 results as support for the higher fair value range, suggesting recent execution is tracking ahead of what was previously baked into targets around $10.INTT: Solid 2026 Guidance And Q4 Execution Will Support Higher Earnings Multiple
Analysts have nudged their fair value estimate for inTEST up from $19 to $20, citing recent price target increases to $14 and $19 following better-than-expected Q4 results and solid 2026 guidance. Analyst Commentary Bullish analysts are pointing to inTEST's recent Q4 results and 2026 guidance as key reasons for lifting their fair value views, reflected in updated price targets of $14 and $19.INTT: Raised Outlook Into 2026 Will Support Repriced Earnings Multiple
Analysts have lifted their price target on inTEST to $19 from $12, citing recent Q4 outperformance, "solid" guidance into 2026, and updated assumptions for revenue growth, profit margins, discount rate, and future P/E. Analyst Commentary Bullish analysts are pointing to inTEST's recent Q4 performance and the company's guidance into 2026 as key reasons for lifting their valuation ranges.INTT: Medical Device Test Order Will Support Balanced Outlook Through 2026
Analysts have slightly adjusted their price targets on inTEST, reflecting small refinements to discount rate, revenue growth, profit margin and future P/E assumptions within their updated models. Taken together, these changes point to a modestly revised view of the stock's potential value in dollar terms.INTT: Medical Device Testing Expansion Will Support Measured Outlook For 2026 Recovery
Analysts have trimmed their fair value estimate for inTEST to $10.00. This reflects slightly lower discount rate and future P/E assumptions alongside modestly adjusted revenue growth and profit margin expectations.INTT: Transition-Year Execution Will Set Up 2026 Recovery And Undervalued Upside
Analysts have raised their price target on inTEST to US$10 from US$8, indicating increased confidence in the company's longer term growth outlook as it moves past a transition year. Analyst Commentary Recent research highlights a more optimistic stance on inTEST, with the latest work describing 2025 as a transition year and pointing to the potential for growth in 2026.INTT: Transition-Year Execution And 2026 Recovery Outlook Will Support Bullish Thesis
Narrative Update: Analyst Price Target Shift for inTEST The consensus analyst price target for inTEST has moved up by US$2 to US$10 per share. This reflects analysts' higher confidence in the company's outlook as it progresses through a transition year and they look ahead to 2026.INTT 2026 Recovery Outlook Will Drive Confidence In Transition-Year Progress
Analysts have raised their price target on inTEST to $10 from $8 per share, reflecting increased confidence in the company’s positioning for a return to growth after its current transition period. Analyst Commentary Recent research commentary reflects a cautiously optimistic stance, with the latest price target increase framed against a backdrop of execution and macro risks that could weigh on the pace of inTEST's recovery.
Alfamation Integration And Malaysian Expansion Will Strengthen Future Prospects
Integration with Alfamation and innovative product lines are enhancing revenue and margins, leveraging synergies, and expanding the customer base.Desglose de ingresos y gastos
Cómo gana y gasta dinero InTest. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 26 | 121 | 1 | 39 | 10 |
| 31 Dec 25 | 114 | -3 | 39 | 9 |
| 30 Sep 25 | 118 | -2 | 42 | 9 |
| 30 Jun 25 | 122 | -1 | 43 | 9 |
| 31 Mar 25 | 128 | 0 | 41 | 9 |
| 31 Dec 24 | 131 | 3 | 41 | 9 |
| 30 Sep 24 | 122 | 3 | 40 | 8 |
| 30 Jun 24 | 123 | 5 | 40 | 8 |
| 31 Mar 24 | 121 | 7 | 39 | 8 |
| 31 Dec 23 | 123 | 9 | 39 | 8 |
| 30 Sep 23 | 128 | 11 | 39 | 8 |
| 30 Jun 23 | 128 | 11 | 37 | 8 |
| 31 Mar 23 | 125 | 11 | 37 | 8 |
| 31 Dec 22 | 117 | 8 | 35 | 8 |
| 30 Sep 22 | 107 | 6 | 33 | 7 |
| 30 Jun 22 | 97 | 5 | 30 | 7 |
| 31 Mar 22 | 89 | 6 | 28 | 6 |
| 31 Dec 21 | 85 | 7 | 25 | 6 |
| 30 Sep 21 | 77 | 7 | 23 | 5 |
| 30 Jun 21 | 71 | 5 | 21 | 5 |
| 31 Mar 21 | 62 | 2 | 19 | 5 |
| 31 Dec 20 | 54 | -1 | 19 | 5 |
| 30 Sep 20 | 53 | 0 | 19 | 5 |
| 30 Jun 20 | 53 | 0 | 19 | 5 |
| 31 Mar 20 | 54 | 0 | 20 | 5 |
| 31 Dec 19 | 61 | 2 | 21 | 5 |
| 30 Sep 19 | 65 | 1 | 22 | 5 |
| 30 Jun 19 | 71 | 0 | 22 | 5 |
| 31 Mar 19 | 78 | 4 | 23 | 5 |
| 31 Dec 18 | 79 | 3 | 22 | 5 |
| 30 Sep 18 | 80 | -1 | 22 | 5 |
| 30 Jun 18 | 77 | 2 | 22 | 5 |
| 31 Mar 18 | 71 | -1 | 21 | 5 |
| 31 Dec 17 | 67 | 1 | 19 | 4 |
| 30 Sep 17 | 58 | 7 | 16 | 4 |
| 30 Jun 17 | 51 | 6 | 14 | 4 |
| 31 Mar 17 | 46 | 5 | 13 | 4 |
| 31 Dec 16 | 40 | 3 | 12 | 4 |
| 30 Sep 16 | 38 | 2 | 12 | 4 |
| 30 Jun 16 | 36 | 1 | 12 | 4 |
| 31 Mar 16 | 37 | 2 | 12 | 4 |
| 31 Dec 15 | 39 | 2 | 12 | 4 |
| 30 Sep 15 | 41 | 3 | 12 | 4 |
| 30 Jun 15 | 42 | 3 | 12 | 4 |
Ingresos de calidad: INTT tiene una única gran pérdida de $1.3M que afecta a sus resultados financieros de los últimos 12 meses de 31st March, 2026.
Margen de beneficios creciente: INTT pasó a ser rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de INTT han disminuido en un 28.2% al año en los últimos 5 años.
Acelerando crecimiento: INTT ha pasado a ser rentable en el último año, lo que dificulta la comparación de la tasa de crecimiento de los beneficios con su promedio de 5 años.
Beneficios vs. Industria: INTT ha pasado a ser rentable en el último año, lo que es difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Semiconductor (22.6%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de INTT (0.6%) se considera baja.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/06/04 13:01 |
| Precio de las acciones al final del día | 2026/06/04 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
InTest Corporation está cubierta por 4 analistas. 3 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Maxwell Michaelis | Lake Street Capital Markets, LLC |
| Edward Jackson | Northland Capital Markets |
| Richard Ryan | Oak Ridge Financial Services Group Inc. |